The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases

This study showed that CRS and HIPEC can be performed with an acceptable morbidity and mortality in Indian patients. Most of the surgeons are on the learning curve and further improvement in these outcomes is expected over a period of time. Pooling of data related to both common and rare peritoneal cancers would be useful in knowing the disease behavior, response to treatment and outcomes in Indian patients. The 2015 PSOGI meeting provided a unique platform for data presentation with feedback from international experts in the field of peritoneal surface oncology. Future meetings are planned to expand the evaluation of Indian data and progress. (Source: Indian Journal of Surgical Oncology)

from MedWorm: Mesothelioma http://www.medworm.com/index.php?rid=164542884&cid=c_409_6_f&fid=39470&url=http%3A%2F%2Flink.springer.com%2F10.1007%2Fs13193-016-0500-x